bdmlu
Posts:16
I'm looking for Dr Inhoe's presentation giving updated results from Alectinib trial. Can someone help me with that? I see tweets of many of the other presentations and a video by Dr Govindan, but not the abstract with new data. Thanks for any help!
Forums
Reply # - November 3, 2014, 01:49 PM
Hi b daddy,
Hi b daddy,
I'm not finding anything on Dr. Inhoe through the Grace search but we do have posts on the subject of alectinib. I'm going to ask Craig to comment. He's a layperson who has has nsclc with a ROS1 mutation and with as good a knowledge of what's going on with ALK/ROS1 treatments as anyone. Not only all that but he's very active in social media driven to help.
The first 2 results may have new information on alectinib, http://cancergrace.org/search-results?q=Alectinib
All best,
Janine
Reply # - November 3, 2014, 02:24 PM
Thanks Janine.
Thanks Janine.
Reply # - November 3, 2014, 03:37 PM
I am not able to locate any
I am not able to locate any such material either.
Often at conference like that details (presentation videos or images of poster displays) are available for attendees to refer to subsequently (and sometimes to fully paid members of the org hosting the event), though they can take weeks to appear online. I only attend the annual ASCO presentation and am not a member of ASCO, so I don't have access to this event's materials. I cannot even locate a reference of a Dr. Inhoe as doing research on alectinib. Are you sure that is the name you're looking for? If that is the speaker, you can probably try to contact him/her directly and ask for a copy of his/her presentation.
Best hopes,
Craig
in PA
Reply # - November 3, 2014, 07:06 PM
Thanks Craig. Well I
Thanks Craig. Well I misspelled the name, it's Inoue, but still doesn't churn up a lot of Google hits. I'll take your advice and keep looking for an email address. I did send Genentech inquiries by email and tweet but nothing yet.
Reply # - November 3, 2014, 10:20 PM
I don't see a publicly
I don't see a publicly available abstract. I attended the meeting, and it was really just a rehash of data already presented and/or published elsewhere, just now with a few larger numbers and more followup. But the findings and conclusions are really exactly what we've seen for more than a year.
-Dr. West
Reply # - November 4, 2014, 07:06 AM
bdaddy,
bdaddy,
FYI - I assume you mean the Akira Inoue at this med school in Japan:
http://www.rm.med.tohoku.ac.jp/english/class03.html
but I cannot guess his email address, not unless you get lucky guessing something like
inoue@rm.med.tohoku.ac.jp or
ainoue@rm.med.tohoku.ac.jp or
a.inoue@rm.med.tohoku.ac.jp
Best hopes,
Craig
Reply # - November 4, 2014, 02:43 PM
Dr West and Dr Craig,
Dr West and Dr Craig,
Thanks for working this for me. Even though I was hoping for some new ground, the same old same old on Alectinib is not bad, so I'll take it. I think that's where Andy probably will go just as soon as the Expanded Access trial opens up, as he has leptomeningeal and vertebral mets but no progression elsewhere. Meanwhile he's added Alimta and Carboplatin to Xalkori and trying to skate until the trial starts recruiting. So far he's asymptomatic and feels great.